Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Research
Associate Member, St. Jude Faculty
Infectious Diseases
Virology
Charles Russell, PhD
Infectious Diseases
MS 330, Room I-6309
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: charles.russell@stjude.org
Phone: (901) 595-5648
FAX: (901) 595-8559
PhD - University of California at Berkeley
BS - Chemistry, Millikin University
Russell CJ. Stalking Influenza Diversity with a Universal Antibody. The New England Journal of Medicine 365:1541-2, 2011.
DuBois RM*, Zaraket H*, Reddivari M, Heath RJ, White SW, Russell CJ. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathogens 7:e1002398, 2011. *joint 1st author
Burke CW*, Mason JN*, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, Russell CJ. Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. PLoS Pathogens 7:e1002134, 2011. *joint 1st author
DuBois RM, Aguilar‐Yañez JM, Mendoza‐Ochoa GI, Oropeza-Almazán Y, Schultz-Cherry S, Alvarez MM, White SW, Russell CJ. The receptor-binding domain of influenza virus hemagglutinin protein produced in Escherichia coli folds into its native, immunogenic structure. J Virol 85:865-872, 2011.
Aguilar-Yáñez JM, Portillo-Lara R, Mendoza-Ochoa GI, García-Echauri SA, López-Pacheco F, Bulnes-Abundis D, Salgado-Gallegos J, Lara-Mayorga IM, Webb-Vargas Y, Angel FOL, Rivero-Aranda RE, Ruiz-PalaciosGM, Zertuche-Guerra MI, DuBois RM, White SW, Schultz-Cherry S, Russell CJ, and Alvarez MM. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5:e11694, 2010.
Vanderlinden E, Göktaş F, Cesur Z, Froeyen M, Reed ML, Russell CJ, Cesur N, Naesens L. Novel inhibitors of influenza virus fusion: structure activity relationship and interaction with the viral hemagglutinin. J Virol 84:4277-4288, 2010.
Reed ML, Bridges OA, Seiler P, Kim J-K, Yen H-L, Salomon R, Govorkova EA, Webster RG, Russell CJ. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84:1527-1535, 2010.
Luque LE, Bridges OA, Mason JN, Boyd KL, Portner A, Russell CJ. Residues in the heptad repeat A region of the fusion (F) protein modulate the virulence of Sendai virus in mice. J Virol 84:810-821, 2010.
Boyd V, Mason J, Hanumesh P, Price J, Russell CJ, Webb TR. 2-Substituted-4,5-Dihydroxypyrimidine-6-Carboxamide RNA-Dependent RNA Polymerase Targeted Libraries. J Combinatorial Chem 11:1100-1104, 2009.
Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, Taylor G, Xiong X, Yan X, Portner A, Alymova IV. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Antimicrob Agents Chemother 53:3942-3951, 2009.
Reed ML, Yen H-L, DuBois RM, Bridges OA, Salomon R, Webster RG, Russell CJ. Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin (HA) protein. J Virol 83:3568-3580, 2009.
Jones B, Zhan X, Mishin V, Slobod KS, Surman S, Russell CJ, Portner A, Hurwitz JL. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. Vaccine 27:1848-1857, 2009.
Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T, Jones B, Surman S, Russell CJ, Portner A, Hurwitz JL. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 26:3480-3488, 2008.
Luque LE, Russell CJ. Spring-loaded heptad repeat residues regulate the expression and activation of the paramyxovirus fusion (F) protein. J Virol 81:3130-3141, 2007.
Ilyushina NA, Govorkova EA, Russell CJ, Hoffman E, Webster RG. Contribution of H7 hemagglutinin to anantadine resistance and infectivity of influenza virus. J Gen Virol 88:1266-1274, 2007.
Russell CJ, Luque LE. The structural basis of paramyxovirus invasion. Trends Microbiol 14:243-246, 2006.
Russell CJ, Webster RG. The genesis of a pandemic influenza virus. Cell 123:368-371, 2005.
Russell CJ, Jardetzky TS, Lamb RA. Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state. J Virol 78:13727-13742, 2004.
Waning DL, Russell CJ, Jardetzky TS, Lamb RA. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci USA 101:9217-9222, 2004.
Russell CJ, Kantor KL, Jardetzky TS, Lamb RA. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol 163:363-374, 2003.
Takeda M, Leser GP, Russell CJ, Lamb RA. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA 100:14610-14617, 2003.
Russell CJ, Jardetzky TS, Lamb RA. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO Journal 20:4024-4034, 2001.
Last update: February 2012
